Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience.
Karayalcin G, Behm FG, Gieser PW, Kung F, Weiner M, Tebbi CK, Ferree C, Marcus R, Constine L, Mendenhall NP, Chauvenet A, Murphy SB. Karayalcin G, et al. Among authors: chauvenet a. Med Pediatr Oncol. 1997 Dec;29(6):519-25. doi: 10.1002/(sici)1096-911x(199712)29:6<519::aid-mpo1>3.0.co;2-n. Med Pediatr Oncol. 1997. PMID: 9324338
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD Jr, Chauvenet AR. Weiner MA, et al. Among authors: chauvenet ar. J Clin Oncol. 1997 Aug;15(8):2769-79. doi: 10.1200/JCO.1997.15.8.2769. J Clin Oncol. 1997. PMID: 9256118 Clinical Trial.
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.
Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A. Tebbi CK, et al. Among authors: chauvenet a. Pediatr Blood Cancer. 2012 Dec 15;59(7):1259-65. doi: 10.1002/pbc.24279. Epub 2012 Aug 21. Pediatr Blood Cancer. 2012. PMID: 22911615 Free PMC article. Clinical Trial.
Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.
Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA. Fernández KS, et al. Among authors: chauvenet a. Pediatr Blood Cancer. 2017 Dec;64(12):10.1002/pbc.26681. doi: 10.1002/pbc.26681. Epub 2017 Jun 14. Pediatr Blood Cancer. 2017. PMID: 28612375 Free PMC article.
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR; Children's Oncology Group. Kung FH, et al. J Pediatr Hematol Oncol. 2006 Jun;28(6):362-8. doi: 10.1097/00043426-200606000-00008. J Pediatr Hematol Oncol. 2006. PMID: 16794504 Clinical Trial.
112 results